Archive

Natural immunity and protecting children

Written by | 12 Mar 2022

Covid is far less serious for children, long-covid is not a big issue and many also have natural immunity – all of which raises questions over whether children […]

Covid passports – the questions to ask

Written by | 11 Mar 2022

There are several theoretical reasons for implementing vaccine passports but now that none of these apply any longer in the UK it is difficult to see a rationale […]

Covid vaccination – the knowns and unknowns

Written by | 10 Mar 2022

Many factors influence decisions about vaccine use including many ‘unknowns’ and this raises questions about the wisdom of targeting young people and recommending boosters for everyone, explains Allyson […]

Mass testing – in theory and in practice

Written by | 9 Mar 2022

There was no evidence that mass testing stopped or prevented the transmission of covid-19, according to Professor Allyson Pollock, Clinical Professor of Public Health, Newcastle University. “Mass testing […]

Evidence-based public health: Covid control measures

Written by | 8 Mar 2022

As the coronavirus pandemic appears to be running out of steam it is important to review the lessons learned and move forward to ‘living with the virus’. IMI […]

Revocation of vaccine mandates – effective 15th March

Written by | 1 Mar 2022

90% of respondents supported revocation of the vaccine mandate, in a public consultation exercise carried out in February 2022. The UK Government has today (March 1st) published its […]

Implications of findings for disease flare and vaccine reactions in RMD patients

Written by | 8 Feb 2022

With low rates of disease flare and reactogenicity after vaccination, the study findings are reassuring for both patients and clinicians, according to Dr Caoilfhionn Connolly, Rheumatology Fellow at […]

Disease flare and reactogenicity after covid vaccination in RMD patients

Written by | 7 Feb 2022

A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the […]

Don’t bet on lottery to boost vaccine uptake

Written by | 9 Jan 2022

Most people offered a COVID-19 vaccine in 2021 kept their appointment and rolled up their sleeves. However, as the year wore on, some countries struggled with vaccine hesitancy. […]

New study associates mask laws to reduction of COVID-19 deaths

Written by | 28 Dec 2021

Countries without face mask mandates experienced significantly higher COVID-19 deaths per million than countries that enacted mask mandates, investigators report in the American Journal of Preventive Medicine. A […]

Supermeres’ may carry clues to cancer, Alzheimer’s disease and COVID-19

Written by | 24 Dec 2021

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, […]

Molnupiravir – what you need to know

Written by | 10 Dec 2021

Molnupiravir has been approved by the MHRA for early treatment of mild-moderate covid-19 in vulnerable adults, it was announced on 4th November. It is good news that at […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.